Feedback / Questions
64/67Cu SAR-bisPSMA theranostic - Clarity Pharma
https://www.prnewswire.com/news-releases/claritys-theranostic-prostate-cancer-trial-progresses-at-the-highest-dose-level-cohort-302000099.html
Nov 29, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next